Navigation Links
Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration
Date:10/27/2011

TUCSON, Ariz., Oct. 27, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today a first-of-its-kind integration of the VIRTUOSO digital pathology software and VANTAGE workflow management solution, bringing unprecedented workflow integration to the anatomic pathology lab.

The VIRTUOSO -VANTAGE integration enables pathologists and lab managers to track the progress of a slide from preparation to digitization along with other critical slide information, giving the lab unprecedented visibility into their processes to optimize lab workflow.

"In our continuing effort to further improve our comprehensive solution for the AP Lab, we asked pathologists and lab managers several key questions," explained Steve Burnell, PhD, lifecycle leader for advanced workflow. "How do you obtain feedback on slide quality from the pathologist? How do you ensure that cases reviewed are of the highest quality? How do you receive updates on the status of cases or urgent orders? The integration of VIRTUOSO with VANTAGE effectively answers these questions by providing complete visibility into key laboratory processes such as workflow events, case history, slide quality and slide processing."

With this integrated solution, Pathologists using VIRTUOSO will be able to:

  • Check the histology status of a pending slide
  • Review the entire histology processing history of a slide
  • Provide image quality feedback to the histotechnologist for corrective action tracking

Lab managers using VANTAGE will be able to:

  • Review the pathologist workflow of a case
  • Run quality reports on digital slides

The VANTAGE workflow solution is another Ventana first in the industry. It automates, streamlines, and integrates lab work and information flow to provide maximum productivity and patient safety gains. VIRTUOSO image management software is a web-based application that orchestrates the workflow around the digital slide, from the moment the slide is scanned until the slide image is viewed and the results reported.

With this integration, slide data is now seamlessly shared between VIRTUOSO and VANTAGE. This facilitates the exchange of information between pathologists and lab managers, resulting in improved communications and a more streamlined workflow while maintaining high quality. Workflow optimization is becoming increasingly important in modern pathology labs, particularly as lab professionals adopt digital pathology into their existing glass slide workflow.

Ventana provides complete digital pathology solutions. The iScan Coreo Au slide scanner is integrated with VIRTUOSO for image management functionality from acquisition through reporting.  The VENTANA iScan HT slide scanner, launching soon, will also be integrated with VIRTUOSO.  To view the entire suite of digital pathology products, including the VIRTUOSO -VANTAGE integration, visit Ventana at booth #200 during Pathology Visions 2011 at the Manchester Grand Hyatt, San Diego, from Oct. 30 – Nov. 4, 2011.  The VENTANA iScan HT is for research use only. Not for use in diagnostic procedures.  Ventana products are for in vitro diagnostic use for specific applications, and are research use only for other applications.

About Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc. ("VMSI") (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company's "Smart Systems" – intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, VMSI is driving personalized medicine through accelerated drug discovery and the development of "companion diagnostics" to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.

VENTANA, the VENTANA logo, VANTAGE, iScan,  and VIRTUOSO are trademarks of Roche.

VMSI Media Relations:

Jacqueline Bucher
Director, Corporate Communications
Phone: 520-877-7288
e-mail: jacquie.bucher@ventana.roche.com


'/>"/>
SOURCE Ventana Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Endologix Announces First Clinical Implant of Ventana™ Stent Graft
2. CareGiver, Ventana Medical Systems, Inc. Remote Instrument Support, Has Expanded to Include the Ventana BenchMark ULTRA Automated Stainer
3. Ventana Medical Systems, Inc. Launches Virtuoso Software for Digital Pathology
4. Ventana Medical Systems, Inc. Receives FDA Approval for the First Fully Automated Diagnostic Assay for HER2 Gene Status Determination in Breast Cancer Patients
5. Ventana Medical Systems, Inc. Unveils High-throughput Slide Scanner for Digital Pathology
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. Globus Medical Raises $110 Million in Series E Financing Round
10. Quark Pharmaceuticals Appoints New Chief Medical Officer
11. Boston University Biomedical Engineers Find Chink in Bacterias Armor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):